Diabetes and Heart Disease Highlights From ACC 2022 Diabetes and Heart Disease Highlights From ACC 2022
Dr Martha Gulati shares key reports from ACC 2022, including updates on SGLT2 inhibitors from the SCORED trial, chronic hypertension in pregnancy, and heart-healthy diet education in supermarkets.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology ReCAP Source Type: news
More News: Cardiology | Diabetes | Diets | Education | Endocrinology | Health | Heart | Heart Disease | Hypertension | Nutrition | Pregnancy | SGLT2 Inhibitors | Universities & Medical Training